Latest News about LGVN
Recent news which mentions LGVN
2 Moonshot Biotechs with 10x Potential
November 22, 2021
From InvestorPlace
52 Biggest Movers From Friday
November 22, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week
November 21, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Falls 200 Points; Connect Biopharma Shares Tumble
November 19, 2021
From Benzinga
Mid-Day Market Update: Crude Oil Down Over 4%; UWM Holdings Shares Surge
November 19, 2021
From Benzinga
33 Stocks Moving In Friday's Mid-Day Session
November 19, 2021
From Benzinga
Mid-Morning Market Update: Markets Mixed; Foot Locker Profit Beats Views
November 19, 2021
From Benzinga
From InvestorPlace
20 Stocks Moving in Friday's Pre-Market Session
November 19, 2021
From Benzinga
54 Biggest Movers From Yesterday
November 19, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Falls 75 Points; Dicerna Pharmaceuticals Shares Spike Higher
November 18, 2021
From Benzinga
LGVN Stock Alert: The Huge FDA News Sending Longeveron to the Moon Today
November 18, 2021
Tickers
LGVN
From InvestorPlace
Mid-Day Market Update: Macy's Surges After Q3 Results; Amtech Systems Shares Plunge
November 18, 2021
From Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
November 18, 2021
From Benzinga
From Benzinga
Earnings Scheduled For November 12, 2021
November 12, 2021
From Benzinga
5 Cheap Stocks Set to Double This Month
November 02, 2021
From InvestorPlace
7 Penny Stocks to Buy to Sidestep the Noise on Wall Street
October 21, 2021
From InvestorPlace
2 Moonshot Stocks Insiders Have Suddenly Started Buying
October 15, 2021
From InvestorPlace
3 Penny Stocks Insiders Are Buying
October 15, 2021
From Benzinga
2 Penny Stocks Insiders Are Buying
October 13, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 04, 2021
From Benzinga
Longeveron Successfully Advancing its Cell-Based Therapy Studies in a Growing Industry Segment
October 04, 2021
Tickers
LGVN
From Benzinga
EXCLUSIVE: Longeveron Announces Biomarker Analysis Data From Mid-Stage Study Of Anti-Aging Cell Therapy Candidate
September 29, 2021
Tickers
LGVN
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.